Lamivudine Tablet, Film Coated
Product Images NDC 64380-711

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 64380-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 01

Chemical structure of lamivudine showing its molecular framework with nitrogen, oxygen, sulfur atoms, and hydroxyl group arranged in a bicyclic structure.*

FDA Label Image

E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 02

A line graph comparing the proportions of subjects with HIV-1 RNA levels below 400 copies/mL over 48 weeks of treatment time for Lamivudine 150 mg twice daily and Lamivudine 300 mg once daily. The graph shows similar effectiveness between the two dosing regimens over the treatment period.*

FDA Label Image

E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 03

Label for Lamivudine Tablets USP 150 mg, film-coated oral tablets. The label indicates the manufacturer as Strides Pharma Science Limited and includes distributor information for Strides Pharma Inc. It specifies a package size of 60 tablets and shows an NDC number 64380-710-03. The label also features storage instructions and a barcode.*

FDA Label Image

E4e113f6 182c 4bf8 9cc9 Cdf1fccfc996 04

Lamivudine Tablets, USP 300 mg film-coated oral tablets in a 30-tablet blister pack. The label shows the dosage strength, manufacturer as Strides Pharma Science Limited, and distributor as Strides Pharma Inc. It includes storage instructions and a barcode on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.